# Treatment of Prostate Cancer With Firmagon®

> **NCT01710098** · — · COMPLETED · sponsor: **United Clinic Management GmbH** · enrollment: 100 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Degarelix

## Key facts

- **NCT ID:** NCT01710098
- **Lead sponsor:** United Clinic Management GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06
- **Primary completion:** 2014-06
- **Final completion:** 2015-09-24
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2020-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01710098

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01710098, "Treatment of Prostate Cancer With Firmagon®". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT01710098. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*